$FGEN FIBROGEN INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in FIBROGEN INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in FIBROGEN INC. Insider overview, share value development, latest insider transactions and email notifications about new events in FIBROGEN INC for free.

CIK Number: 0000921299
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: FGEN
Company Address: 409 ILLINOIS STREET SAN FRANCISCO 94158
Phone number: 415-978-1200

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Market Capitalization: $1.47B
Prev close: $23.90
Average Daily Volume: 565,902
Days Low: $22.70
Year Low: $14.50
Year High: $25.70

FIBROGEN INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Chung ChristineSVP, China Operations166,5973,981,668shares bought: 193,930 / shares sold: -198,482 SELLMar 10 20212 months ago
Conterno Enrique AChief Executive Officer137,2733,280,825shares bought: 229,800 / shares sold: -5,411 STRONG BUYFeb 26 20213 months ago
Controneo PatSVP, Finance and CFO282,1876,744,269shares bought: 724,674 / shares sold: -588,387 BUYMar 10 20212 months ago
KEARNS THOMAS F JRDirector166,1643,971,320shares bought: 121,100 / shares sold: -108,500 BUYMar 15 20212 months ago
Kouchakji EliasSVP, Clinical Dev, Drug Safety147,3463,521,569shares bought: 88,464 / shares sold: -40,827 STRONG BUYMar 10 20212 months ago
Kurkijarvi KaleviDirector39,100934,490shares bought: 207,100 / shares sold: -240,000 SELLFeb 19 20213 months ago
Wettig ThaneChief Commercial Officer47,1501,126,885shares bought: 46,500 / shares sold: 0 STRONG BUYFeb 26 20213 months ago

View all FIBROGEN INC insiders.

FIBROGEN INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 15 2021FGENFIBROGEN INCKEARNS THOMAS F JRDirectorOption ExerciseM3.506,00021,0000
Mar 15 2021FGENFIBROGEN INCKEARNS THOMAS F JRDirectorOption ExerciseM3.5012,00042,0000
Mar 15 2021FGENFIBROGEN INCKEARNS THOMAS F JRDirectorSellS35.0218,000630,360148,164166.2 K to 148.2 K (-10.83 %)
Mar 15 2021FGENFIBROGEN INCKEARNS THOMAS F JRDirectorBuyM3.5018,00063,000166,164148.2 K to 166.2 K (+12.15 %)
Mar 10 2021FGENFIBROGEN INCKouchakji EliasSVP, Clinical Dev, ...Payment of ExerciseF33.375,221174,225147,346152.6 K to 147.3 K (-3.42 %)
Mar 10 2021FGENFIBROGEN INCCotroneo PatSVP, Finance and CF ...Payment of ExerciseF33.375,657188,774282,187287.8 K to 282.2 K (-1.97 %)
Mar 10 2021FGENFIBROGEN INCChung ChristineSVP, China Operatio ...Payment of ExerciseF33.375,679189,508166,597172.3 K to 166.6 K (-3.30 %)
Feb 26 2021FGENFIBROGEN INCWettig ThaneChief Commercial Of ...Option ExerciseA53.0132,1001,701,62132,100
Feb 26 2021FGENFIBROGEN INCWettig ThaneChief Commercial Of ...GrantA0.0016,500047,15030.7 K to 47.2 K (+53.83 %)
Feb 26 2021FGENFIBROGEN INCKouchakji EliasSVP, Clinical Dev, ...Option ExerciseA53.0139,9002,115,09939,900
Feb 26 2021FGENFIBROGEN INCKouchakji EliasSVP, Clinical Dev, ...GrantA0.0020,8000152,567131.8 K to 152.6 K (+15.79 %)
Feb 26 2021FGENFIBROGEN INCCotroneo PatSVP, Finance and CF ...Option ExerciseA53.0141,7002,210,51741,700
Feb 26 2021FGENFIBROGEN INCCotroneo PatSVP, Finance and CF ...GrantA0.0021,7000287,844266.1 K to 287.8 K (+8.15 %)
Feb 26 2021FGENFIBROGEN INCChung ChristineSVP, China Operatio ...Option ExerciseA53.0141,7002,210,51741,700
Feb 26 2021FGENFIBROGEN INCChung ChristineSVP, China Operatio ...GrantA0.0021,7000172,276150.6 K to 172.3 K (+14.41 %)

View all FIBROGEN INC insider transactions.